Deutsche Bank’s Precision BioSciences DTIL Stock Holding History

Deutsche Bank’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$128K	Sell	20,469 -2,939	-13%	-$22.2K	﹤0.01%	3277
2026 Q2	$184K	Buy	+23,408	New	+$165K	﹤0.01%	3303
2023 Q1	–	Sell	-3,949	Closed	-$141K	–	3932
2022 Q4	$141K	Hold	3,949	–	–	﹤0.01%	3157
2022 Q3	$154K	Buy	3,949 +18	+0.5%	+$855	﹤0.01%	3093
2022 Q2	$189K	Sell	3,931 -2,349	-37%	-$138K	﹤0.01%	3210
2022 Q1	$580K	Sell	6,280 -157	-2%	-$21.3K	﹤0.01%	2658
2021 Q4	$1.43M	Buy	6,437 +4,042	+169%	+$1.13M	﹤0.01%	2217
2021 Q3	$829K	Sell	2,395 -493	-17%	-$167K	﹤0.01%	2733
2021 Q2	$1.08M	Buy	2,888 +879	+44%	+$264K	﹤0.01%	2711
2021 Q1	$623K	Buy	2,009 +297	+17%	+$104K	﹤0.01%	2965
2020 Q4	$429K	Buy	1,712 +844	+97%	+$207K	﹤0.01%	3007
2020 Q3	$160K	Buy	868 +73	+9%	+$14.5K	﹤0.01%	3327
2020 Q2	$199K	Buy	795 +376	+90%	+$82.3K	﹤0.01%	3147
2020 Q1	$76K	Sell	419 -24	-5%	-$6.28K	﹤0.01%	3360
2019 Q4	$184K	Buy	443 +357	+415%	+$112K	﹤0.01%	3277
2019 Q3	$20K	Sell	86 -308	-78%	-$100K	﹤0.01%	4317
2019 Q2	$156K	Buy	+394	New	+$159K	﹤0.01%	3971

Other funds holding DTIL

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Deutsche Bank's DTIL Position: Q3 2026 in Review

Deutsche Bank reduced its Precision BioSciences (DTIL) stake by 13% in Q3 2026, selling an estimated $22.2K and leaving 20,469 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #3277.

Deutsche Bank first reported a position in DTIL in Q2 2019 and has held it in 17 quarters since. The position peaked at $1.43M in Q4 2021. 40 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.

Deutsche Bank held 20,469 shares of Precision BioSciences worth $128K as of Q3 2026.
Deutsche Bank sold 2,939 Precision BioSciences shares in Q3 2026, an estimated $22.2K.
Precision BioSciences made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3277 holding.
Deutsche Bank first reported a position in Precision BioSciences in Q2 2019 and has held it in 17 quarters since.
Deutsche Bank's Precision BioSciences position peaked at $1.43M in Q4 2021.
40 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.